Myalgia rheumatica—more formally called polymyalgia rheumatica (PMR)—often causes new pain and stiffness around both shoulders, sometimes with aching in the hips, neck or thighs. Morning stiffness commonly lasts more than 45 minutes and can make dressing, getting out of bed or raising your arms difficult. These symptoms are a reason to arrange a medical assessment, not a diagnosis: no single blood test or response to steroids can confirm PMR on its own.
How Myalgia Rheumatica Is Assessed
PMR almost always affects people over 50. A clinician will ask when symptoms began, where they are, how long stiffness lasts after waking and how they affect everyday movement. They may check your range of motion and look for signs pointing to another cause. PMR can limit movement because of pain and stiffness, but it does not typically cause true muscle weakness.
Blood tests for inflammation usually include the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Raised results support the possibility of PMR in someone with a typical symptom pattern, but they are not specific to it. Infection and other inflammatory conditions can also raise them. Conversely, normal results do not automatically rule PMR out; suspected PMR with normal inflammatory markers may warrant specialist assessment.
There is no definitive diagnostic test. Clinicians consider the whole picture and may investigate alternatives such as rheumatoid arthritis, osteoarthritis, thyroid problems, muscle disease or medication-related pain. Classification criteria can help organize that assessment, but they are not a stand-alone diagnostic test.
A study by Charlotta Fors and colleagues reviewed records for 188 people diagnosed with PMR at two primary-care clinics in Helsingborg, Sweden, between 2000 and 2013. An independent rheumatologist supported 60% of the diagnoses overall; agreement was higher among those meeting a modified ACR/EULAR classification set. Morning stiffness was not documented in 74% of records. This retrospective study of two clinics does not establish how often PMR is misdiagnosed elsewhere. It does underline why a careful history—including the duration of morning stiffness—matters.
What Steroid Treatment And Tapering Involve
Clinicians commonly treat PMR with a low daily dose of a glucocorticoid: often prednisone in the United States or prednisolone in the United Kingdom and some other countries. A typical starting range is 12.5–25 mg daily, but the right plan depends on the person and the clinician’s assessment. Many people improve promptly, sometimes within 24–72 hours. That response can support the diagnosis, but it does not prove it; other conditions can also improve with steroids, and not everyone with PMR feels fully better within a few weeks.
The dose is usually reduced gradually once symptoms and inflammation are controlled. Treatment often lasts at least a year and can take longer. As one example of local practice, an NHS Lanarkshire pathway starts at 15 mg, then reduces to 12.5 mg and 10 mg before slower reductions of 1 mg every 4–8 weeks. This is an example, not a schedule to copy: tapering plans vary between guidelines and individuals. Don’t change your dose or stop steroids suddenly without discussing it with your clinician.
At follow-up, your clinician may review pain, stiffness, function and ESR or CRP, alongside possible steroid effects. Long-term glucocorticoids can contribute to problems such as high blood pressure, raised blood sugar and osteoporosis, so ask how your bone health and other risks will be monitored. A return of symptoms during a reduction is worth reporting; the dose may need review, and persistent or difficult-to-control symptoms may prompt specialist input.
Know The Warning Signs Of Giant Cell Arteritis
PMR can occur with giant cell arteritis (GCA), an inflammation of blood vessels that can threaten vision. Tell a clinician urgently if you develop a new or severe headache, scalp tenderness, pain or fatigue in your jaw while chewing, or any change in vision, such as blurring or brief loss of sight. Sudden vision loss needs emergency assessment. Do not wait for a routine PMR appointment or try to adjust steroid doses yourself. Read more about giant cell arteritis warning signs.
Because GCA needs prompt assessment, mention these symptoms clearly when you seek care and say if you have PMR or are taking steroids. For ongoing shoulder and hip-girdle stiffness, arrange a clinician’s assessment rather than relying on a blood result or a trial of someone else’s medication.






















